Table 3_Carbapenem-resistant enterobacterales in sterile body fluids: ten-year population

Shenyun Cao's dataset comprises 62 non-duplicate Carbapenem-Resistant Enterobacterales (CRE) isolates from sterile body fluids at a tertiary hospital between 2016 and 2025. The data includes whole-genome sequencing results for molecular epidemiology, resistance and virulence gene profiles, sequence types, and associated clinical risk factors. It was last updated on June 2, 2026, and is shared under a CC-BY-4.0 license.

Use Cases

• Analyzing the prevalence of specific carbapenemase genes (e.g., blaKPC-2, blaNDM-1) and sequence types (e.g., ST11) among CRE isolates.
• Investigating associations between clinical factors like ICU admission and patient mortality outcomes.
• Studying the co-occurrence of virulence genes (e.g., rmpA2) with multidrug resistance profiles in bacterial genomes.
• Performing phylogenetic analysis to identify clonal clusters and transmission patterns within a hospital based on SNP data.

Strengths

• 62 clinically significant isolates from sterile body fluids over a ten-year period (2016-2025).
• Data includes detailed genomic analysis covering resistance genes, virulence factors, plasmid profiles, and MLST.
• Clinical risk factor data, such as ICU admission, is linked to microbiological findings and patient outcomes.

Limitations

• The dataset is small in scale at 72.5 KB, with an unknown row count.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is sourced from a single tertiary hospital, which may limit generalizability.

Provenance

Source

Shenyun Cao via figshare.

Collection Method

Retrospective analysis of clinical isolates using VITEK-2 Compact for MICs and Illumina NovaSeq for whole-genome sequencing.

Time Range

2016 to 2025.

Freshness

Last updated 2026-06-02 05:42:27; freshness should be verified.